Skip to main content
NewslettersWatchlist

Stryker Corp(SYK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low326.59
Day High337.03
Open:336.07
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
1 'Strong Buy' Growth Stock Wall Street Expects to Soar Around 70%
The Globe and Mail
Top RRSP investment picks from three veteran advisors
Barchart
Stocks Slump as Fed Signals No Rush to Cut Interest Rates
Barchart
Stocks Slide as Tech Earnings Disappoint
Barchart
Markets Today: Tech Earnings Weigh on Stocks as FOMC Results Awaited
MarketBeat
Medtronic: oversold, overextended high yield reversal in play
The Globe and Mail
Healthcare equipment stocks are struggling but here’s a winner
AllPennyStocks.com
Microcap Offers Unique Opportunity for Investors In $10 Billion SCI Industry
MarketBeat
The Value Deepens for Medtech Stocks: Reversal Imminent
The Globe and Mail
13 financial stable stocks
Motley Fool
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
PR Newswire
Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact
PR Newswire
A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras
PR Newswire
How Artificial Intelligence is Bolstering Impressive Billion Dollar Growth Opportunities in Healthcare Sector
MarketBeat
AMC Stock: The Horror Film Traders Keep Showing Up For
Barchart
Stocks Mixed as Weak China and European Economic News Sparks Risk-Off Sentiment
Barchart
Markets Today: Stocks Weighed Down by Disappointing Chinese and European Economic News
MarketBeat
A Significant Reversal is in Sight for These 5 Med Tech Companies
MarketBeat
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
Motley Fool
Is This MedTech Giant a Buy for Dividend Investors?
Barchart
Stocks Dragged Lower by Losses in Apple
Barchart
Stocks Move Lower After a Rocky Week of Trading
PR Newswire
Stryker launches national direct-to-patient marketing campaign
Motley Fool
3 Stocks That Could Help You Retire a Millionaire
PR Newswire
Stryker launches industry's only fully autonomous guidance system
MarketBeat
Bullish Action: Chipotle, Visa, Stryker Break Through Resistance
Barchart
Stocks End Holiday-Shortened Session Slightly Higher
Barchart
Stocks Slightly Lower as U.S. Manufacturing Activity Unexpectedly Contracts
Motley Fool
Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend
MarketBeat
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
Motley Fool
This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?
Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life

Profile

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.